Structure's experimental pill shows 11% weight loss in study, shares up
Dec 8 (Reuters) - Structure Therapeutics GPCR.O said on Monday that its obesity pill showed a 11.3% reduction in weight in a mid-stage study. Shares of the biotech jumped 41.8% in premarket trading. (Reporting by Puyaan Singh in Bengaluru; Editing by Shailesh Kuber) ((Puyaan.Singh@thomsonreuters.com;))
Recent news on Structure Therapeutics
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Structure falls as investors await more obesity trial data, says Jefferies